PT909175E - Formulacoes nao aquosas de peptidos proticos - Google Patents

Formulacoes nao aquosas de peptidos proticos

Info

Publication number: PT909175E
Authority: PT; Portugal
Prior art keywords: protic; peptides; aqueous formulations; formulations; aqueous
Prior art date: 1996-07-03

Application number

PT97930181T

Other languages

English (en)

Inventor

Jeremy C Wright

Sally A Tao

Steven J Prestrelski

Cynthia L Stevenson

James B Eckenhoff

Joe Leonard

Original Assignee

Alza Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-03

Filing date

1997-07-01

Publication date

2003-10-31

1997-07-01 Application filed by Alza Corp filed Critical Alza Corp

2003-10-31 Publication of PT909175E publication Critical patent/PT909175E/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Gynecology & Obstetrics (AREA)
Oil, Petroleum & Natural Gas (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)

PT97930181T 1996-07-03 1997-07-01 Formulacoes nao aquosas de peptidos proticos PT909175E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US2112996P	1996-07-03	1996-07-03

Publications (1)

Publication Number	Publication Date
PT909175E true PT909175E (pt)	2003-10-31

Family

ID=21802501

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT97930181T PT909175E (pt)	1996-07-03	1997-07-01	Formulacoes nao aquosas de peptidos proticos

Country Status (27)

Country	Link
EP (1)	EP0909175B1 (pt)
JP (3)	JP2001504802A (pt)
CN (1)	CN1231256C (pt)
AR (1)	AR008060A1 (pt)
AT (1)	ATE241997T1 (pt)
AU (1)	AU737664B2 (pt)
BR (1)	BR9710130A (pt)
CA (1)	CA2259403A1 (pt)
CO (1)	CO4890854A1 (pt)
CZ (1)	CZ433898A3 (pt)
DE (1)	DE69722620T2 (pt)
DK (1)	DK0909175T3 (pt)
ES (1)	ES2201306T3 (pt)
HU (1)	HUP9903942A3 (pt)
ID (1)	ID19165A (pt)
IL (1)	IL127769A (pt)
MY (1)	MY121684A (pt)
NO (1)	NO323933B1 (pt)
NZ (1)	NZ333580A (pt)
PL (1)	PL189402B1 (pt)
PT (1)	PT909175E (pt)
RO (1)	RO119862B1 (pt)
RU (1)	RU2203085C2 (pt)
SK (1)	SK284490B6 (pt)
TW (1)	TW491703B (pt)
WO (1)	WO1998000152A1 (pt)
ZA (1)	ZA975942B (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2259403A1 (en) *	1996-07-03	1998-01-08	Alza Corporation	Non-aqueous protic peptide formulations
US7919109B2 (en)	1999-02-08	2011-04-05	Intarcia Therapeutics, Inc.	Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US7258869B1 (en)	1999-02-08	2007-08-21	Alza Corporation	Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US20030119734A1 (en)	2001-06-28	2003-06-26	Flink James M.	Stable formulation of modified GLP-1
US7731947B2 (en)	2003-11-17	2010-06-08	Intarcia Therapeutics, Inc.	Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US7772188B2 (en)	2003-01-28	2010-08-10	Ironwood Pharmaceuticals, Inc.	Methods and compositions for the treatment of gastrointestinal disorders
US20040247671A1 (en) *	2003-04-25	2004-12-09	Prescott James H.	Solid drug formulation and device for storage and controlled delivery thereof
CN1882356B (zh) *	2003-11-20	2015-02-25	诺沃挪第克公司	对于生产和用于注射装置中是最佳的含有丙二醇的肽制剂
WO2006083761A2 (en)	2005-02-03	2006-08-10	Alza Corporation	Solvent/polymer solutions as suspension vehicles
US11246913B2 (en)	2005-02-03	2022-02-15	Intarcia Therapeutics, Inc.	Suspension formulation comprising an insulinotropic peptide
CN101453982B (zh)	2006-05-30	2011-05-04	精达制药公司	两件式内部通道渗透递送系统流动调节器
DK2359808T3 (da)	2006-08-09	2013-08-05	Intarcia Therapeutics Inc	Osmotiske leveringssystemer og stempelaggregater
AU2013203271B2 (en) *	2007-01-19	2016-05-12	Hananja Ehf	Methods and compositions for the delivery of a therapeutic agent
US20080275030A1 (en)	2007-01-19	2008-11-06	Sveinbjorn Gizurarson	Methods and Compositions for the Delivery of a Therapeutic Agent
CN106389330A (zh) *	2007-01-19	2017-02-15	哈南亚有限公司	用于递送治疗剂的方法和组合物
EP2157967B1 (en)	2007-04-23	2013-01-16	Intarcia Therapeutics, Inc	Suspension formulations of insulinotropic peptides and uses thereof
ES2717154T3 (es)	2007-06-22	2019-06-19	Univ Texas	Formación de partículas de péptido o proteína submicrométricas estables mediante congelación de película fina
EP2240155B1 (en)	2008-02-13	2012-06-06	Intarcia Therapeutics, Inc	Devices, formulations, and methods for delivery of multiple beneficial agents
EP2315571A4 (en) *	2008-07-16	2013-05-01	Surmodics Pharmaceuticals Inc	METHOD FOR PRODUCING MICROPARTICLES WITH BIOACTIVE PEPTIDES
US20120213846A1 (en)	2008-08-15	2012-08-23	Forest Laboratories Holdings Limited	Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration
KR20110103961A (ko)	2008-11-16	2011-09-21	보드 오브 리전츠 더 유니버시티 오브 텍사스 시스템	저점도 고농축 현탁액
US8748573B2 (en)	2009-08-06	2014-06-10	Ironwood Pharmaceuticals, Inc.	Formulations comprising linaclotide
DK2462246T3 (da)	2009-09-28	2017-11-06	Intarcia Therapeutics Inc	Hurtig etablering og/eller afslutning af væsentlig steady-state-lægemiddelafgivelse
DK2536742T3 (en)	2010-02-17	2017-09-04	Ironwood Pharmaceuticals Inc	TREATMENTS FOR GASTROINTESTINAL DISORDERS
EP2603232B1 (en)	2010-08-11	2019-09-25	Ironwood Pharmaceuticals, Inc.	Stable formulations of linaclotide
US20120208755A1 (en)	2011-02-16	2012-08-16	Intarcia Therapeutics, Inc.	Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
WO2013025969A1 (en)	2011-08-17	2013-02-21	Ironwood Pharmaceuticals, Inc.	Treatments for gastrointestinal disorders
JP2013231030A (ja) *	2012-04-30	2013-11-14	Sun Pharmaceutical Industries Ltd	リュープロリド注射剤
WO2014124096A1 (en) *	2013-02-06	2014-08-14	Perosphere Inc.	Stable glucagon formulations
EP2823808A1 (en) *	2013-07-09	2015-01-14	Ipsen Pharma S.A.S.	Pharmaceutical composition for a sustained release of lanreotide
US9889085B1 (en)	2014-09-30	2018-02-13	Intarcia Therapeutics, Inc.	Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
EP3302354B1 (en)	2015-06-03	2023-10-04	i2o Therapeutics, Inc.	Implant placement systems
MA53353A (fr)	2016-05-16	2021-06-09	Intarcia Therapeutics Inc	Polypeptides sélectifs pour le récepteur du glucagon et méthodes pour leur utilisation
USD840030S1 (en)	2016-06-02	2019-02-05	Intarcia Therapeutics, Inc.	Implant placement guide
USD860451S1 (en)	2016-06-02	2019-09-17	Intarcia Therapeutics, Inc.	Implant removal tool
KR20190104039A (ko)	2017-01-03	2019-09-05	인타르시아 세라퓨틱스 인코포레이티드	Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법
EP3372224A1 (en)	2017-03-07	2018-09-12	Alrise Biosystems GmbH	New controlled drug delivery system using water miscible solvents for production of drug loaded micro- and nanoparticles
MY198425A (en)	2017-08-24	2023-08-29	Novo Nordisk As	Glp-1 Compositions and uses Thereof
US20230082544A1 (en)	2020-02-18	2023-03-16	Novo Nordisk A/S	Pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4897256A (en) *	1986-11-25	1990-01-30	Abbott Laboratories	LHRH analog formulations
DE3886880T2 (de) *	1987-10-15	1994-07-14	Syntex Inc	Pulverförmige Zubereitungen zur intranasalen Verabreichung von Polypeptiden.
IT1237197B (it) *	1989-11-16	1993-05-26	Sclavo Spa	Formulazioni farmaceutiche anidre e forme di dosaggio per la somministrazione rettale di calcitonina.
ATE156361T1 (de) *	1992-09-21	1997-08-15	Upjohn Co	Proteinhaftige arzneimittel mit verzögerter wirkstoffabgabe
RU2143889C1 (ru) *	1993-02-23	2000-01-10	Генентек, Инк.	Способ стабилизации полипептида, способы получения композиций полипептида и композиции
US5955430A (en) *	1993-09-24	1999-09-21	University Of Southern California	Use of angiotensin II fragments and analogs thereof in tissue repair
JP3597233B2 (ja) *	1993-10-21	2004-12-02	久光製薬株式会社	経鼻組成物及びそれを含有する経鼻製剤
CA2259403A1 (en) *	1996-07-03	1998-01-08	Alza Corporation	Non-aqueous protic peptide formulations

1997
- 1997-07-01 CA CA002259403A patent/CA2259403A1/en not_active Abandoned
- 1997-07-01 AU AU34073/97A patent/AU737664B2/en not_active Ceased
- 1997-07-01 WO PCT/US1997/010815 patent/WO1998000152A1/en not_active Application Discontinuation
- 1997-07-01 HU HU9903942A patent/HUP9903942A3/hu unknown
- 1997-07-01 CZ CZ984338A patent/CZ433898A3/cs unknown
- 1997-07-01 AT AT97930181T patent/ATE241997T1/de active
- 1997-07-01 PT PT97930181T patent/PT909175E/pt unknown
- 1997-07-01 JP JP50421898A patent/JP2001504802A/ja not_active Withdrawn
- 1997-07-01 DE DE69722620T patent/DE69722620T2/de not_active Expired - Lifetime
- 1997-07-01 PL PL97330869A patent/PL189402B1/pl not_active IP Right Cessation
- 1997-07-01 ES ES97930181T patent/ES2201306T3/es not_active Expired - Lifetime
- 1997-07-01 SK SK1799-98A patent/SK284490B6/sk not_active IP Right Cessation
- 1997-07-01 NZ NZ333580A patent/NZ333580A/en not_active IP Right Cessation
- 1997-07-01 EP EP97930181A patent/EP0909175B1/en not_active Expired - Lifetime
- 1997-07-01 RO RO98-01769A patent/RO119862B1/ro unknown
- 1997-07-01 DK DK97930181T patent/DK0909175T3/da active
- 1997-07-01 RU RU99102540/14A patent/RU2203085C2/ru not_active IP Right Cessation
- 1997-07-01 CN CNB971960534A patent/CN1231256C/zh not_active Expired - Fee Related
- 1997-07-01 IL IL127769A patent/IL127769A/en not_active IP Right Cessation
- 1997-07-01 BR BR9710130A patent/BR9710130A/pt not_active Application Discontinuation
- 1997-07-02 AR ARP970102967A patent/AR008060A1/es unknown
- 1997-07-03 ID IDP972315A patent/ID19165A/id unknown
- 1997-07-03 MY MYPI97003024A patent/MY121684A/en unknown
- 1997-07-03 CO CO97037097A patent/CO4890854A1/es unknown
- 1997-07-03 ZA ZA9705942A patent/ZA975942B/xx unknown
- 1997-08-22 TW TW086109392A patent/TW491703B/zh not_active IP Right Cessation
1998
- 1998-12-30 NO NO19986209A patent/NO323933B1/no not_active IP Right Cessation
2008
- 2008-04-23 JP JP2008112307A patent/JP2008195739A/ja active Pending
2009
- 2009-10-05 JP JP2009231256A patent/JP2010043105A/ja active Pending

Also Published As

Publication number	Publication date
NZ333580A (en)	2000-06-23
HUP9903942A3 (en)	2000-07-28
AR008060A1 (es)	1999-12-09
MY121684A (en)	2006-02-28
RO119862B1 (ro)	2005-05-30
DE69722620D1 (de)	2003-07-10
HUP9903942A2 (hu)	2000-04-28
ES2201306T3 (es)	2004-03-16
NO323933B1 (no)	2007-07-23
BR9710130A (pt)	1999-08-10
RU2203085C2 (ru)	2003-04-27
JP2010043105A (ja)	2010-02-25
IL127769A0 (en)	1999-10-28
DE69722620T2 (de)	2004-04-29
JP2001504802A (ja)	2001-04-10
SK284490B6 (sk)	2005-05-05
CN1224356A (zh)	1999-07-28
SK179998A3 (en)	1999-05-07
NO986209L (no)	1998-12-30
AU3407397A (en)	1998-01-21
TW491703B (en)	2002-06-21
PL189402B1 (pl)	2005-08-31
ID19165A (id)	1998-06-28
EP0909175A1 (en)	1999-04-21
AU737664B2 (en)	2001-08-30
CZ433898A3 (cs)	1999-04-14
ZA975942B (en)	1998-04-16
DK0909175T3 (da)	2003-09-29
CN1231256C (zh)	2005-12-14
CO4890854A1 (es)	2000-02-28
PL330869A1 (en)	1999-06-07
CA2259403A1 (en)	1998-01-08
JP2008195739A (ja)	2008-08-28
NO986209D0 (no)	1998-12-30
IL127769A (en)	2006-10-31
EP0909175B1 (en)	2003-06-04
WO1998000152A1 (en)	1998-01-08
ATE241997T1 (de)	2003-06-15

Publication	Publication Date	Title
PT909175E (pt)	2003-10-31	Formulacoes nao aquosas de peptidos proticos
BR9710132A (pt)	1999-08-10	Formulações de peptídeos apróticos polares não-aquosos
DE69737478D1 (de)	2007-04-26	Miniaturspektrometer
NO990643D0 (no)	1999-02-11	Tienopyrimidiner
DK0794378T3 (da)	2002-03-18	Koblingsindretning
EP0968223A4 (en)	2007-11-21	BIOKON JUGATION OF MACROMOLECULES
DE59703982D1 (de)	2001-08-16	Zielscheibenanordnung
DE69739490D1 (de)	2009-08-20	Schaltanlage
DE69731020D1 (de)	2004-11-11	Schaltgerät
DE69737921D1 (de)	2007-08-30	Verbesserter optischer Schalter/Modulator
DE59702237D1 (de)	2000-09-28	Abtrennvorrichtung
DE59712097D1 (de)	2004-12-30	Elektronenstrahl-Linse
DE69735239D1 (de)	2006-04-20	Hochfrequenzschalter
DE59702841D1 (de)	2001-02-08	Endoskopoptik
DE59700539D1 (de)	1999-11-11	Schaltgerät
DE59812193D1 (de)	2004-12-09	Hochspannungsschaltanlage
DE69822586D1 (de)	2004-04-29	Luftziel
DE69633499D1 (de)	2004-11-04	Optischer Schalter
GB9603380D0 (en)	1996-04-17	Fats beam bridge
DE69816908D1 (de)	2003-09-11	Schaltgerät
FR2744244B1 (fr)	1998-03-06	Telescope
KR970010731U (ko)	1997-03-29	완구용 망원경
SE9703113D0 (sv)	1997-08-28	High-voltage switchgear
KR970027179U (ko)	1997-07-24	타켓 포인트
ES1037710Y (es)	1998-11-01	Juego de habilidad